Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration

Purpose. To report our experiences in patients with age-related macular degeneration (AMD) treated initially with intravitreal ranibizumab and then switched to bevacizumab. Methods. We retrospectively reviewed the records of 7 patients (7 eyes) who were treated with monthly injections of intravitrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Kisaburo, Kimoto, Kenichi, Kono, Hirofumi, Kubota, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912580/
https://www.ncbi.nlm.nih.gov/pubmed/24555120
http://dx.doi.org/10.5402/2011/916789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912580/
https://www.ncbi.nlm.nih.gov/pubmed/24555120
http://dx.doi.org/10.5402/2011/916789

Ejemplares similares